• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[造影剂不透射线物质、造影剂浓度以及注入时间对造影剂排泄和副作用发生率的影响(作者译)]

[Influence of radiopaque substance and concentration of contrast media as well as time of infusion on excretion of contrast medium and incidence of side effects (author's transl)].

作者信息

Schmerwitz W, Rösch E

出版信息

Rontgenblatter. 1977 Feb;30(2):71-8.

PMID:576505
Abstract

Two hepatotropic contrast media in 3 different concentrations each are administered to a total of 727 patients for infusion cholecystography. It is the purpose of the study to investigate frequency of adverse reactions and quality of radiographic demonstration. In regard to tolerance, Endomirabil clearly shows advantages over Biligram. The radiologic demonstration of Endomirabil is somewhat better than with Biligram. The frequency of adverse reactions shows to be influenced by the concentration of the contrast medium as well as time of infusion, which particularly applies to Endomirabil, while in regard to the quality of visualization, ni dependence on either concentration of infusion time could be demonstrated.

摘要

将两种不同浓度的肝靶向造影剂分别以三种不同浓度给予总共727例患者进行静脉胆囊造影。本研究的目的是调查不良反应的发生率和放射学显示质量。在耐受性方面,恩多米拉比必利胆显明显更具优势。恩多米拉的放射学显示比必利胆显稍好。不良反应的发生率受造影剂浓度和输注时间的影响,这在恩多米拉中尤为明显,而在可视化质量方面,未发现对浓度或输注时间有依赖性。

相似文献

1
[Influence of radiopaque substance and concentration of contrast media as well as time of infusion on excretion of contrast medium and incidence of side effects (author's transl)].[造影剂不透射线物质、造影剂浓度以及注入时间对造影剂排泄和副作用发生率的影响(作者译)]
Rontgenblatter. 1977 Feb;30(2):71-8.
2
[Injection cholecystography--influence of radiopaque substance and injection time on the excretion of contrast media and incidence of side effects].[胆囊造影注射法——不透射线物质及注射时间对造影剂排泄及副作用发生率的影响]
Rontgenblatter. 1977 Feb;30(2):64-70.
3
[A contribution to the rate of side-effects of hepatotropic contrast media. A clinical comparative study of iodoxamate (Endomirabil) and ioglycamid (Bilivistan) (author's transl)].[关于肝脏造影剂副作用发生率的一项贡献。碘多啥胺(恩多米拉比尔)和碘甘酰胺(必利维斯坦)的临床对比研究(作者译)]
Radiologe. 1977 Feb;17(2):70-3.
4
[Studies on the biliary excretion of the hepatotropic contrast media ioglycamate and iotroxinate in pigs and men (author's transl)].[猪和人肝细胞特异性造影剂碘甘氨酸盐和碘托酸盐的胆汁排泄研究(作者译)]
Rontgenblatter. 1978 Feb;31(2):114-9.
5
[Tolerance and contrast density in intravenous cholangiography and cholecystography using a new contrast medium (author's transl)].使用一种新型造影剂的静脉胆管造影和胆囊造影中的耐受性与对比密度(作者译)
Rontgenblatter. 1978 Oct;31(10):596-9.
6
[Clinical experiences with iodoxamic acid in the cholecystography-cholangiography (author's transl)].碘多啥酸在胆囊造影 - 胆管造影中的临床经验(作者译) [此处原文中“iodoxamic acid”可能有误,推测应为“iodipamide”之类更常见的造影剂名称,不过按照要求准确翻译就是这样]
Med Klin. 1976 Oct 29;71(44):1885-90.
7
[The results and tolerability of infusion cholegraphy using ioglycamide-85 (12.75 g meglumine salt in 75 ml) in comparison with the use of a hypotonic adipiodone solution (10 g meglumine salt in 100 ml)].使用碘甘卡胺-85(75毫升中含12.75克葡甲胺盐)进行注入式胆囊造影的结果及耐受性与使用低渗碘番酸溶液(100毫升中含10克葡甲胺盐)的比较
Radiol Diagn (Berl). 1990;31(3):253-60.
8
[Quality of roentgenological visualization and tolerance of various intravenous cholegraphic contrast media (author's transl)].[各种静脉胆系造影剂的X线显影质量及耐受性(作者译)]
Rontgenblatter. 1980 Nov;33(11):581-7.
9
[Clinical experience with a new intravenous contrast medium, BC-17 in cholecystography and cholangiography (author's transl)].新型静脉造影剂BC - 17在胆囊造影和胆管造影中的临床经验(作者译)
Nihon Igaku Hoshasen Gakkai Zasshi. 1974 Oct 25;34(10):725-34.
10
[Pharmacokinetics and plasma albumen binding of iotroxic acid (Biliscopin), iodoxic acid (Endomirabil) and ioglycamine (Biligram) (author's transl)].碘曲酸(必利胆平)、碘多酸(恩多米拉必尔)和碘甘胺(必利格拉姆)的药代动力学及血浆白蛋白结合率(作者译)
Rofo. 1977 Mar;126(3):262-7. doi: 10.1055/s-0029-1230576.